ETX — E-Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for E-Therapeutics, fiscal year end - January 31st, GBP millions except per share, conversion factor applied.

	2021 January 31st	R2022 January 31st	2023 January 31st	2024 January 31st	2025 January 31st
Period Length:	12 M	—	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	13	26.4	31.7	20.7	32.7
Net Total Accounts Receivable
Net Total Receivables	0.826	1.71	1.76	2.4	3.39
Prepaid Expenses
Total Current Assets	14.1	28.6	34	23.6	36.5
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.08	0.805	0.4	0.988	0.831
Net Goodwill
Net Intangible Assets
Long Term Investments
Total Assets	14.3	29.5	34.6	25	38.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	0.427	1.49	1.6	2.66	2.12
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	0.427	1.79	1.6	2.98	2.12
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	13.9	27.7	33	22	36.1
Total Liabilities & Shareholders' Equity	14.3	29.5	34.6	25	38.2
Total Common Shares Outstanding